ArticleFrontiers in cellular and infection microbiology2026
Clinical characteristics and epidemiological analysis of 23 cases of tick-borne rickettsiosis in Xinjiang Uygur Autonomous Region.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Previously, at least ten spotted fever group Methods: During April 2017 - May 2025, the blood samples of 70 tick-bitten patients in XUAR were collected. Their blood DNAs were individually extracted, and rickettsia-specific gene fragments were further detected by nested polymerase chain reaction (nPCR). Meanwhile, combined with sequencing of 16S rRNA V3/V4 region in blood pools and serological examination, clinical symptoms, laboratory test results and antibiotic treatment were further analyzed. Results: Out of 70 tick-bitten cases, 23 patients were confirmed to be infected with SFGR, including Conclusion: In this study of 70 tick-bitten patients who visited the First Affiliated Hospital of Shihezi University from April 2017 to May 2025, the SFGR infection rate was 32.9% (23/70). Early diagnosis and timely treatment are crucial in spotted fever cases. Early administration of doxycycline is effective against SFGR infection, and delayed treatment increases the risk of severe outcomes. The methods of nucleic acid diagnosis, such as nPCR and next-generation sequencing (NGS), should be implemented especially in acute tick-bitten patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.